Hospital News

      Hospital News

      Merck’s KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery

      RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck’s KEYTRUDA Met Primary Endpoint of Disease-Free Survival in Certain Patients With Muscle-Invasive Urothelial Carcinoma After Surgery
      Admin -

      Recent Articles

      Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia

      Regulatory Affairs

      Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors

      Look Who’s On the Move!

      OliX Pharmaceuticals Announces Positive Safety Data and Preliminary Efficacy Effects in a Phase 1 Trial of OLX10212 for Age-Related Macular Degeneration

      Industry News

      Phenomic Enters Strategic Collaboration with Boehringer Ingelheim to Discover Novel Targets for Stroma-Rich Cancer Therapies

      Industry News

      JP Kotha Appointed Vice President, Bioanalytical at Worldwide Clinical Trials

      Look Who’s On the Move!

      New Data Show Durable Response Following Treatment with ADSTILADRIN® (nadofaragene firadenovec-vncg)

      Industry News

      Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors

      Look Who’s On the Move!

      Japan’s Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics’ ARCT-154, the First Self-Amplifying mRNA Vaccine Approved for COVID in Adults

      Regulatory Affairs

      bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

      Regulatory Affairs

      Curative Appoints Brandon Charles as New Chief Medical Officer

      Look Who’s On the Move!

      AWS Joins Forces With Amgen on Generative AI Solutions to Accelerate Advanced Therapies

      Industry News

      Agomab Appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer

      Industry News

      The problem with clinical trials (and how virtual insight-gathering can help)

      Featured Authors

      Genmab Announces Positive Regulatory Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma

      Regulatory Affairs

      Avilar Therapeutics Receives U.S. Patent for Novel Extracellular Protein Degraders

      Regulatory Affairs

      2021 © Copyright - TPMG